Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES III

Table 2 Mortality in IgA anti-tTG positive individuals based on follow-up time^a

Follow-up	tTGA+ Deaths	tTGA- Deaths	Adjusted HR; 95 % CI	P value	Absolute risk/1000 PYAR	Excess risk/1000 PYAR
All	58	2996	1.43; 1.10–1.85	0.007	74	22
Year <1	8	134	3.52; 1.72–7.20	0.001	100	72
1–4.99	19	778	1.58; 1.00–2.49	0.051	70	26
5+	31	2084	1.18; 0.83–1.69	0.354	71	11

Reference is general population comparator cohort
tTGA tissue transglutaminase antibody, PYAR Person-years at risk
^aAll hazard ratios (HRs) were adjusted for sex, race, age, and ever smoking. See text for additional explanation

ISSN: 1471-230X